↓ Skip to main content

Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, January 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)

Mentioned by

twitter
7 tweeters

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
14 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference
Published in
Journal of Pharmaceutical Policy and Practice, January 2021
DOI 10.1186/s40545-021-00300-3
Authors

Vogler, Sabine, Zimmermann, Nina, Babar, Zaheer-Ud-Din, Busse, Reinhard, Espin, Jaime, Mantel-Teeuwisse, Aukje K., Panteli, Dimitra, Suleman, Fatima, Wirtz, Veronika J.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Librarian 2 14%
Student > Ph. D. Student 2 14%
Other 2 14%
Researcher 2 14%
Lecturer > Senior Lecturer 1 7%
Other 1 7%
Unknown 4 29%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 21%
Medicine and Dentistry 3 21%
Nursing and Health Professions 1 7%
Decision Sciences 1 7%
Economics, Econometrics and Finance 1 7%
Other 0 0%
Unknown 5 36%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 February 2021.
All research outputs
#5,576,068
of 20,219,854 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#123
of 359 outputs
Outputs of similar age
#133,248
of 407,515 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#1
of 1 outputs
Altmetric has tracked 20,219,854 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 359 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 407,515 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them